Observational studyMedical oncology (Northwood, London, England)2015

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.

Gilles Freyer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.